Viewing Study NCT00134004


Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2026-01-22 @ 4:22 PM
Study NCT ID: NCT00134004
Status: COMPLETED
Last Update Posted: 2015-10-06
First Post: 2005-08-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: J0457 CDR0000440990
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View